It will be a matter of debate whether oligosarcoma should be recognized as a distinct tumor type or rather as a distinct subtype in the overarching tumor type 'oligodendroglioma, IDH-mutant and 1p/19q-codeleted'. This evidence concerns the gene IDH2 and oligodendroglioma.